+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Hypertrophic and Keloid Scar Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Scar Indication (Hypertrophic Scars, Keloid Scars), By Product (Topical Products , Laser Therapy Products , Injectable Therapies , Cryotherapy & Surface Ablation Systems), By Distribution Channel & End-User (Hospitals & Wound Care Centers, Dermatology & Plastic Surgery Clinics, Retail Pharmacies & Drugstores, E-commerce & Direct-to-Consumer Platforms) Companies, and Country Forecast, 2021 to 2034

Global Hypertrophic and Keloid Scar Treatment Market size is forecast to increase from $8 Billion in 2026 to $15.03 Billion in 2034 at a CAGR of 8.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007757
Pages: 212 Pages

Hypertension Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Calcium Channel Blockers , Angiotensin-Converting Enzyme , Angiotensin II Receptor Blockers , Diuretics , Beta-Adrenergic Blockers, Vasodilators & Alpha-Blockers), By Condition (Primary , Secondary Hypertension), By Medication Regimen (Monotherapy, Combination Therapy, Fixed-Dose Combinations ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drugstores, Online) Companies, and Country Forecast, 2021 to 2034

Global Hypertension Drugs Market size is forecast to increase from $27.08 Billion in 2026 to $36.49 Billion in 2034 at a CAGR of 3.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007756
Pages: 216 Pages

Hyperspectral Imaging Systems Market Size, Share and Growth Outlook, 2026: Analysis By Component (Hyperspectral Cameras, Accessories & Optics, Software & Data Analytics Tools), By Wavelength Spectrum (Visible & Near-Infrared , Short-Wave Infrared , Mid-Wave Infrared , Long-Wave Infrared ), By Technology (Pushbroom , Snapshot , Whiskbroom , Tunable Filter & Imaging FTIR), By Application Area (Military Surveillance & Defense, Remote Sensing & Geospatial Mapping, Medical Diagnostics & Healthcare, Machine Vision & Optical Sorting, Precision Agriculture & Environmental Monitoring) Companies, and Country Forecast, 2021 to 2034

Global Hyperspectral Imaging Systems Market size is forecast to increase from $1026.43 Million in 2026 to $2596.37 Million in 2034 at a CAGR of 12.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007755
Pages: 215 Pages

Hypersomnia Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Disorder Type (Idiopathic Hypersomnia , Kleine-Levin Syndrome, Secondary Hypersomnia ), By Drug Class (CNS Stimulants , Wake-promoting Agents , Sodium Oxybate, Antidepressants, Emerging Orexin Agonists), By Route of Administration (Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Online) Companies, and Country Forecast, 2021 to 2034

Global Hypersomnia Treatment Market size is forecast to increase from $326.65 Million in 2026 to $468.1 Million in 2034 at a CAGR of 4.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007754
Pages: 228 Pages

Hyperpigmentation Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Treatment Type (Pharmacological Therapy , Laser & Light Therapy , Chemical Peels, Microdermabrasion, Skin Grafting & Surgical Procedures), By Disorder Type (Melasma, Post-Inflammatory Hyperpigmentation , Solar Lentigines , Vitiligo & Albinism), By Product Category (Topical Agents & Cosmeceuticals, Energy-based Devices, Chemical Peel Formulations), By End-User (Dermatology & Aesthetic Clinics, Hospitals & Medical Centers, Homecare) Companies, and Country Forecast, 2021 to 2034

Global Hyperpigmentation Treatment Market size is forecast to increase from $1.93 Billion in 2026 to $3.65 Billion in 2034 at a CAGR of 8.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007753
Pages: 228 Pages

Hyperphosphatemia Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Phosphate Binders , Intestinal Phosphate Transport Inhibitors, Calcimimetics, Vitamin D Analogs), By Patient Population (Chronic Kidney Disease , Non-Dialysis CKD Patients, Pediatric Hyperphosphatemia Patients), By Dosage Form (Oral Tablets & Capsules, Chewable Tablets, Oral Powders & Suspensions), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Hyperphosphatemia Drugs Market size is forecast to increase from $5.21 Billion in 2026 to $8.62 Billion in 2034 at a CAGR of 6.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007752
Pages: 224 Pages

Hyperparathyroidism Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Calcimimetics, Vitamin D Analogs, Phosphate Binders, Bisphosphonates, Parathyroid Hormone ), By Disorder Type (Primary Hyperparathyroidism, Secondary Hyperparathyroidism, Tertiary Hyperparathyroidism), By Route of Administration (Oral, Intravenous, Subcutaneous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Hyperparathyroidism Market size is forecast to increase from $1.39 Billion in 2026 to $2.46 Billion in 2034 at a CAGR of 7.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007751
Pages: 211 Pages

Hyperlipidemia Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Statins, PCSK9 Inhibitors, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, Fibric Acid Derivatives, Combination Therapies, Miscellaneous), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Hyperlipidemia Drugs Market size is forecast to increase from $25.18 Billion in 2026 to $31.41 Billion in 2034 at a CAGR of 2.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007750
Pages: 230 Pages

Hyperkalemia Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Potassium Binders, Beta2 Agonists, Insulin, Diuretics, Sodium Bicarbonate, IV Calcium), By Disease Type (Acute Hyperkalemia, Chronic Hyperkalemia), By Route of Administration (Oral, Intravenous, Inhalation, Rectal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Hyperkalemia Drugs Market size is forecast to increase from $1.85 Billion in 2026 to $5.98 Billion in 2034 at a CAGR of 15.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007749
Pages: 214 Pages

Hyperhidrosis Treatment Market Size, Share and Growth Outlook, 2026: Analysis By Treatment Modality (Topical Antiperspirants & Anticholinergics, Botulinum Toxin A Injections, Iontophoresis Devices, Microwave Thermolysis & Energy-Based Systems, Oral Systemic Medications, Surgical Interventions ), By Disease Type (Primary Focal Hyperhidrosis, Secondary Generalized Hyperhidrosis), By Affected Site (Axillary , Palmar , Craniofacial ), By End-User & Care Setting (Dermatology & Aesthetic Clinics, Hospitals & Ambulatory Surgical Centers, Homecare & Over-the-Counter) Companies, and Country Forecast, 2021 to 2034

Global Hyperhidrosis Treatment Market size is forecast to increase from $758.59 Million in 2026 to $1181.97 Million in 2034 at a CAGR of 5.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007748
Pages: 227 Pages